Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1997;4(3):173–192. doi: 10.1155/MBD.1997.173

Antiviral Metal Complexes

Erik De Clercq 1
PMCID: PMC2365060  PMID: 18475787

Abstract

The initial events (virus adsorption and fusion with the cells) in the replicative cycle of human immunodeficiency virus (HIV) can serve as targets for the antiviral action of metal-binding compounds such as polyanionic compounds (polysulfates, polysulfonates, polycarboxylates, polyoxometalates, and sulfonated or carboxylated metalloporphyrins), bicyclams and G-octet-forming oligonucleotides. The adsorption and fusion of HIV with its target cells depends on the interaction of the viral envelope glycoproteins (gp 120) with the receptors (CD4, CXCR4) at the outer cell membrane. We are currently investigating how the aforementioned compounds interfere with these viral glycoproteins and/or cell receptor.

Full Text

The Full Text of this article is available as a PDF (2.3 MB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES